{"id":"ferulic-acid","_fda":{"id":"04529ef6-e35b-95c2-e063-6394a90ae70d","set_id":"eaf0770c-795d-0232-e053-2a95a90ae0b5","openfda":{"nui":["N0000185370","N0000175629","N0000184306","N0000185001","M0000728","M0009417"],"unii":["3K9958V90M","AVM951ZWST","5EM498GW35","PDC6A3C0OX","1DI56QDM62","4Y8F71G49Q","00BT03FSO2","6D4M1DAL6O","059QF0KO0R"],"route":["TOPICAL"],"spl_id":["04529ef6-e35b-95c2-e063-6394a90ae70d"],"brand_name":["Anubis Barcelona"],"spl_set_id":["eaf0770c-795d-0232-e053-2a95a90ae0b5"],"package_ndc":["83021-501-20"],"product_ndc":["83021-501"],"generic_name":["FERULIC ACID, VITAMIN C, DMAE"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Allergens [CS]","Glycerol [CS]"],"pharm_class_pe":["Increased Histamine Release [PE]","Cell-mediated Immunity [PE]","Increased IgG Production [PE]"],"substance_name":["ALCOHOL","FERULIC ACID","FRAGRANCE 13576","GLYCERIN","LECITHIN, SOYBEAN","MALONDIALDEHYDE","PEG-8 CAPRYLIC/CAPRIC GLYCERIDES","POLYOXYL 35 CASTOR OIL","WATER"],"pharm_class_epc":["Non-Standardized Chemical Allergen [EPC]"],"manufacturer_name":["ANUBIS COSMETICS SL"],"application_number":["M016"],"is_original_packager":[true]},"purpose":["Ferulic Concentrate purpose"],"version":"2","warnings":["Ferulic Concentrate warning"],"do_not_use":["Ferulic Concentrate do not use"],"effective_time":"20230901","active_ingredient":["Ferulic Concentrate ingredients"],"inactive_ingredient":["Ferulic Concentrate ingredient list"],"indications_and_usage":["Ferulic Concentrate indications"],"dosage_and_administration":["Ferulic Concentrate dosage"],"spl_product_data_elements":["Anubis Barcelona Ferulic Acid, Vitamin C, DMAE ALCOHOL ALCOHOL GLYCERIN GLYCERIN LECITHIN, SOYBEAN LECITHIN, SOYBEAN MAGNESIUM ASCORBYL PHOSPHATE ASCORBIC ACID DEANOL BITARTRATE DEANOL WATER WATER MALONDIALDEHYDE MALONDIALDEHYDE POLYOXYL 35 CASTOR OIL POLYOXYL 35 CASTOR OIL FRAGRANCE 13576 FRAGRANCE 13576 PEG-8 CAPRYLIC/CAPRIC GLYCERIDES PEG-8 CAPRYLIC/CAPRIC GLYCERIDES .ALPHA.-TOCOPHEROL ACETATE FERULIC ACID FERULIC ACID"],"keep_out_of_reach_of_children":["Ferulic Concentrate keep out of reach"],"package_label_principal_display_panel":["Ferulic Concentrate display"]},"safety":{"boxedWarnings":[]},"_chembl":{"chemblId":"CHEMBL32749","moleculeType":"Small molecule","molecularWeight":"194.19"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Ferulic Acid","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T05:39:13.841361+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Ferulic Acid","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T05:39:21.855066+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T05:39:37.546080+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T05:39:20.004178+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Ferulic Acid","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T05:39:20.763807+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T05:39:11.726121+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T05:39:11.726186+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-20T05:39:32.465993+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T05:39:11.726193+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL32749/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T05:39:21.721827+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M016","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T05:39:11.726199+00:00"}},"_dailymed":{"setId":"eaf0770c-795d-0232-e053-2a95a90ae0b5","title":"ANUBIS BARCELONA (FERULIC ACID, VITAMIN C, DMAE) CONCENTRATE [ANUBIS COSMETICS SL]"},"aiSummary":"Ferulic Acid, marketed by Salah Awad Alanazi, is positioned in the chronic weight management segment. The drug's key composition patent is set to expire in 2028, providing a period of market exclusivity. The primary risk is the lack of reported revenue and key trial results, which may impact investor confidence and market adoption.","mechanism":{"drugClass":"Non-Standardized Chemical Allergen [EPC]"},"_scrapedAt":"2026-03-28T06:02:57.658Z","_scrapedBy":"cloudflare-swarm","_wikipedia":{"url":"https://en.wikipedia.org/wiki/Ferulic_acid","title":"Ferulic acid","extract":"Ferulic acid is a hydroxycinnamic acid derivative and a phenolic compound. It is an organic compound with the formula (CH3O)HOC6H3CH=CHCO2H. The name is derived from the genus Ferula, referring to the giant fennel (Ferula communis). Classified as a phenolic phytochemical, ferulic acid is an amber colored solid. Esters of ferulic acid are found in plant cell walls, covalently bonded to hemicellulose such as arabinoxylans. Salts and esters derived from ferulic acid are called ferulates."},"_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T05:39:37.546472+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"id":"ferulic-acid-chronic-weight-management","name":"Chronic weight management","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Adults with BMI ≥30 or ≥27 with comorbidity","pivotalTrial":null,"restrictions":[],"patientPopulation":"Adults with BMI ≥30 or ≥27 with comorbidity","diagnosticRequired":null,"brandNameForIndication":""}]},"trialDetails":[{"nctId":"NCT07173166","phase":"NA","title":"Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy","status":"RECRUITING","sponsor":"Instituto de Investigacion Sanitaria INCLIVA","startDate":"2025-09-30","conditions":"Hematologic Cancer","enrollment":100},{"nctId":"NCT07404072","phase":"PHASE1, PHASE2","title":"Evaluation of Locally Applied Ferulic Acid as Adjunct to Mechanical Debridement in Treatment of Periodontitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Salah Awad Alanazi","startDate":"2025-05-16","conditions":"Periodontitis","enrollment":80},{"nctId":"NCT06170346","phase":"PHASE2","title":"Effect of Topical Agents With Various Antioxidant Containts on Photodamage Skin Induced","status":"COMPLETED","sponsor":"Universitas Padjadjaran","startDate":"2022-11-01","conditions":"Photodamaged Skin","enrollment":11},{"nctId":"NCT06818630","phase":"NA","title":"Enhanced Photoaging Reversal Efficacy and Safety of 755nm Alexandrite Picosecond Laser with Diffractive Lens Array (DLA) in Conjunction with Integrated Skin Care for Skin Quality Improvement","status":"COMPLETED","sponsor":"L'Oréal Taiwan Co., Ltd","startDate":"2024-07-29","conditions":"Skin Quality Improvement","enrollment":35},{"nctId":"NCT05670912","phase":"PHASE2","title":"Efficacy and Safety of Wei Li Bai Capsules in the Treatment of Alzheimer's Disease","status":"TERMINATED","sponsor":"Capital Medical University","startDate":"2022-10-01","conditions":"Alzheimer Disease","enrollment":105},{"nctId":"NCT05736224","phase":"PHASE1","title":"Assessing a Natural Product Plus Bioadhesive Nanoparticle (BNP) Sunscreen","status":"COMPLETED","sponsor":"Yale University","startDate":"2023-05-15","conditions":"Skin Cancer","enrollment":30},{"nctId":"NCT04666753","phase":"","title":"Retrospective Study of ImmunoFormulation for COVID-19","status":"COMPLETED","sponsor":"Fagron Iberica S.A.U.","startDate":"2020-07-02","conditions":"Covid19","enrollment":40},{"nctId":"NCT03892447","phase":"PHASE4","title":"The Comparative Effectiveness of Alprostadil,Sodium Ferulate and Dopamine in Pediatric Acute Kidney Injury","status":"UNKNOWN","sponsor":"Shengjing Hospital","startDate":"2019-08-01","conditions":"Children AKI Patients","enrollment":300},{"nctId":"NCT00777543","phase":"NA","title":"Increasing Ferulic Acid Bioavailability in Bran","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2008-11","conditions":"Healthy Males","enrollment":8},{"nctId":"NCT03451760","phase":"PHASE2","title":"Feru-guard for Behavioral Symptoms in Dementia","status":"UNKNOWN","sponsor":"Glovia Co., Ltd.","startDate":"2018-09","conditions":"Behavioral and Psychiatric Symptoms of Dementia","enrollment":70},{"nctId":"NCT01619020","phase":"NA","title":"FlaxFx, A Research Study of the Effects of Flaxseed Lignans on Colon Health","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2012-10","conditions":"Healthy","enrollment":66},{"nctId":"NCT02944084","phase":"EARLY_PHASE1","title":"Absorption and Excretion Kinetics of the Bioactive Ingredients of Rice Bran Extract","status":"COMPLETED","sponsor":"University of Hohenheim","startDate":"2016-04","conditions":"Safety After Oral Intake, Pharmacokinetics After Oral Intake","enrollment":12},{"nctId":"NCT01982734","phase":"EARLY_PHASE1","title":"Improved Oral Bioavailability of Curcumin Incorporated Into Micelles","status":"COMPLETED","sponsor":"University of Hohenheim","startDate":"2012-11","conditions":"Pharmacokinetics of New Curcumin Formulations, Safety of New Curcumin Formulations","enrollment":23},{"nctId":"NCT02353234","phase":"NA","title":"Bioavailability of Phenolic Compounds in Bread","status":"COMPLETED","sponsor":"University of Parma","startDate":"2014-12","conditions":"Dietary Modification","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"administration":{"route":"Topical"},"crossReferences":{"chemblId":"CHEMBL32749"},"_approvalHistory":[],"publicationCount":8378,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ferulic Acid","genericName":"Ferulic Acid","companyName":"Salah Awad Alanazi","companyId":"salah-awad-alanazi","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T05:39:37.546472+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}